Is cardiothoracic point-of-care ultrasonography the future of heart failure diagnosis?

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Download Full-text

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽

10.1093/med/9780198784906.003.0409_update_001 ◽

2018 ◽

pp. 1778-1781

Author(s):

Christian Mueller

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Natriuretic Peptide ◽

Natriuretic Peptides ◽

Point Of Care ◽

Failure Diagnosis ◽

Central Laboratory ◽

Important Advance ◽

Cardiac Stress ◽

Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Download Full-text

Chronic heart failure diagnosis: biomarkers

ESC CardioMed ◽

10.1093/med/9780198784906.003.0409 ◽

2018 ◽

pp. 1778-1781

Author(s):

Christian Mueller

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Natriuretic Peptide ◽

Natriuretic Peptides ◽

Point Of Care ◽

Failure Diagnosis ◽

Central Laboratory ◽

Important Advance ◽

Cardiac Stress ◽

Heart Failure Diagnosis

Natriuretic peptides including B-type natriuretic peptide (BNP), N-terminal (NT)-proBNP, and midregional pro-atrial natriuretic peptide (MR-proANP) are the biomarkers of choice in the diagnosis of heart failure. Assays measuring either BNP, NT-proBNP, or MR-proANP are widely available and run on large analysers operating in the central laboratory or as point-of-care options. Natriuretic peptides are considered quantitative markers of haemodynamic cardiac stress and therefore quantitative markers of heart failure itself. The clinical introduction of natriuretic peptides constitutes the most important advance in the diagnosis of heart failure in the last decade.

Download Full-text